Assessing efficacy of hepatocellular carcinoma prediction scores to prioritise hepatitis B surveillance in the COVID-19 era.

Sinharay, Ricky; Grant, Andrew J; Rivett, Lucy; Blackwell, Rebecca; Mells, George; Gelson, William

Sinharay, Ricky; Grant, Andrew J; Rivett, Lucy; Blackwell, Rebecca; Mells, George; Gelson, William.

Afiliação

Sinharay R; Department of Pathology University of Cambridge Cambridge UK.
Grant AJ; Cambridge Liver Unit Cambridge University Hospitals NHS Foundation Trust Cambridge UK.
Rivett L; MRC Biostatistics Unit University of Cambridge Cambridge UK.
Blackwell R; Department of Infectious Diseases Cambridge University NHS Hospitals Foundation Trust Cambridge UK.
Mells G; Clinical Microbiology and Public Health Laboratory Public Health England Cambridge UK.
Gelson W; Cambridge Liver Unit Cambridge University Hospitals NHS Foundation Trust Cambridge UK.

GastroHep ; 3(2): 80-87, 2021 Mar.

Article em En | MEDLINE | ID: mdl-33821150

Palavras-chave

COVID19; cancer risk scores; cancer surveillance; hepatitis B

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google